Angiotensin II receptor antagonist telmisartan in isolated systolic hypertension (ARAMIS) study: efficacy and safety of telmisartan 20, 40 or 80 mg versus hydrochlorothiazide 12.5 mg or placebo
- Publication date
- 1 January 2004
- Publisher
- 'Ovid Technologies (Wolters Kluwer Health)'